Artículos por temáticas

An Updated Review: Androgens and Cognitive Impairment in Older Men

Cai Z, Li H.

Front Endocrinol (Lausanne). 2020 Nov 13;11:586909. doi: 10.3389/fendo.2020.586909. eCollection 2020.

Status and future directions of clinical trials in Alzheimer's disease

Plascencia-Villa G, Perry G.

Int Rev Neurobiol. 2020;154:3-50. doi: 10.1016/bs.irn.2020.03.022. Epub 2020 Jul 20.

In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer's Disease

Zhang L, Yang S, Wong LR, Xie H, Ho PC.

Mol Pharm. 2020 Nov 2;17(11):4256-4269. doi: 10.1021/acs.molpharmaceut.0c00675. Epub 2020 Oct 21.

Epigenetic Basis of Lead-Induced Neurological Disorders

Wang T, Zhang J, Xu Y.

Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.

Cerebral small vessel disease genomics and its implications across the lifespan

Sargurupremraj M, Suzuki H, Jian X, Sarnowski C, Evans TE, Bis JC, Eiriksdottir G, Sakaue S, Terzikhan N, Habes M, Zhao W, Armstrong NJ, Hofer E, Yanek LR, Hagenaars SP, Kumar RB, van den Akker EB, Mc

Nat Commun. 2020 Dec 8;11(1):6285. doi: 10.1038/s41467-020-19111-2.

Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases

Stanga S, Caretto A, Boido M, Vercelli A.

Int J Mol Sci. 2020 May 25;21(10):3719. doi: 10.3390/ijms21103719.

Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders

Khurana M, Rahman SO, Najmi AK, Pottoo FH, Akhtar MS.

Curr Protein Pept Sci. 2020;21(12):1146-1163. doi: 10.2174/1389203721666201104130135.

The Role of Chemokines in Alzheimer's Disease

Jorda A, Campos-Campos J, Iradi A, Aldasoro M, Aldasoro C, Vila JM, Valles SL.

Endocr Metab Immune Disord Drug Targets. 2020;20(9):1383-1390. doi: 10.2174/1871530320666200131110744.

Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders

Hook V, Yoon M, Mosier C, Ito G, Podvin S, Head BP, Rissman R, O'Donoghue AJ, Hook G.

Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140428. doi: 10.1016/j.bbapap.2020.140428. Epub 2020 Apr 17.

Neprilysin expression and functions in development, ageing and disease

Nalivaeva NN, Zhuravin IA, Turner AJ.

Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer's Disease

Kim JY, Barua S, Jeong YJ, Lee JE.

Int J Mol Sci. 2020 Sep 3;21(17):6419. doi: 10.3390/ijms21176419.

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective

Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Tsai AL, Kent TA.

Prog Neurobiol. 2020 Jan;184:101716. doi: 10.1016/j.pneurobio.2019.101716. Epub 2019 Oct 8.

Brain cell somatic gene recombination and its phylogenetic foundations

Kaeser G, Chun J.

J Biol Chem. 2020 Sep 4;295(36):12786-12795. doi: 10.1074/jbc.REV120.009192. Epub 2020 Jul 22.

Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease

Mihardja M, Roy J, Wong KY, Aquili L, Heng BC, Chan YS, Fung ML, Lim LW.

Ann N Y Acad Sci. 2020 Oct;1478(1):43-62. doi: 10.1111/nyas.14436. Epub 2020 Jul 22.

Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases

Luo F, Sandhu AF, Rungratanawanich W, Williams GE, Akbar M, Zhou S, Song BJ, Wang X.

Int J Mol Sci. 2020 Sep 28;21(19):7174. doi: 10.3390/ijms21197174.